HealthyDirect · GrowthFit for a long SIP
Mahindra Manulife Value Fund
Mahindra Manulife Mutual FundEquity Schemes - Value Fund1.7 years
The scheme seeks to generate long-term capital appreciation from a diversified portfolio of predominantly equity and equity related instruments of companies which are undervalued (or are trading below their intrinsic value).
- NAV
- 11.9893
- 29 Oct 2026
- 1Y
- +0.0%
- Trailing CAGR
- Upside capture
- +117%
- Vs NIFTY 500 TRI
- Downside capture
- +86%
- Lower is better
Buying brief
Should you add this fund?
Evidence on this desk, framed as a purchase checklist - not SEBI-registered advice.
As of 29 Oct 2026
Stance
Fit for a long SIP
Evidence supports keeping this on a shortlist for a multi-year equity SIP.
In three lines
Fits if · The fund beat the category median in 100% of rolling 1-year windows.
Fits if · Peak-to-trough drawdown has stayed shallower than 15%.
Buy checklist
History depth
Fail
1.7 years - thin for judging consistency.
Engine status
Pass
Evidence supports keeping this on a shortlist for a multi-year equity SIP.
Expense ratio
Pass
1.05% TER (Direct). Lower cost compounds on long SIPs.
Drawdown vs peers
Pass
Peak-to-trough -11.5%. Ask whether you can hold through a similar fall.
Vs category
n/a
Category relative read still thin.
Manager tenure
Watch
Krishna Sanghavi · 1.7 years on the scheme.
Exit load
n/a
No exit-load summary on file.
Tax / wrapper
Pass
Direct Growth, no ELSS lock flagged. Equity LTCG rules still apply after one year - not tax advice.
Portfolio concentration
Pass
Top 10 holdings ≈ 29.0% of the portfolio.
Evidence supports a shortlist - confirm with peers before you buy elsewhere.
Before you buy or SIP
Behaviour and wrappers - the usual India MF failure modes - not a buy instruction.
Drawdown rehearsal
This scheme’s worst fall on file is about 11%. Before you SIP, ask whether you would keep contributing through a similar drop - pausing on fear is the usual India MF failure mode.
SIP discipline
If you start a SIP here, diary a 90-day check and an annual review - don’t react to every NAV print.
NAV
Path not in current snapshots
n/a
Returns
Trailing CAGR and simulated monthly SIP XIRR from daily NAV. Category comparison uses the median of comparable share classes in the peer set.
Trailing CAGR
Point-to-point, calendar-day annualized
- 1Y+0.0%
- 3Yn/a
- 5Yn/a
- 10Yn/a
- SI+11.0%
SIP XIRR
Equal monthly instalments to latest NAV
- 1Y-3.7%
- 3Yn/a
- 5Yn/a
- 10Yn/a
- Since inception
- +11.0%
- Calendar-day CAGR
- Excess 1Y
- +7.0%
- Category median, same plan and option
- 3Y win rate
- n/a
- Windows beating the median
- 3Y percentile
- n/a
- Vs comparable share classes
- SIP 3Y XIRR
- n/a
- Simulated monthly SIP
- Worst rolling 3Y
- n/a
- 0 daily-ending windows
- Median rolling 3Y
- n/a
- Calendar-day CAGR
- Positive rolling 5Y
- n/a
- 0 daily-ending windows
Official benchmark
Date-aligned against NIFTY 500 TRI. Capture ratios use common month-end observations through 30 Oct 2026.
- 1Y excess
- +7.6%
- Fund minus TRI
- 3Y excess
- n/a
- Fund minus TRI
- Upside capture
- +117%
- Benchmark-up months
- Downside capture
- +86%
- Lower is better
Drawdown
Peak to trough from a running NAV high, with the path and recovery episodes.
- Max drawdown
- -11.5%
- Worst peak-to-trough
- Current
- -9.0%
- Below last peak
- Current spell
- 64 days
- Days below latest peak
- Time below peak
- +85%
- NAV observations
Drawdown
Path not in current snapshots
n/a
- Average recovery
- 11 days
- 26 recovered episodes
- Longest recovery
- 76 days
- Trough to prior peak
11 Feb 2026 – 22 Apr 2026
Trough 31 Mar 2026 · recovered in 22 days
-11.5%
26 Aug 2026 – open
Trough 23 Oct 2026 · not recovered
-11.3%
24 Mar 2025 – 21 Apr 2025
Trough 7 Apr 2025 · recovered in 14 days
-6.2%
16 Jul 2025 – 23 Oct 2025
Trough 8 Aug 2025 · recovered in 76 days
-5.8%
Dimensions
0–100 reads of named metrics. The mean is unweighted and only uses dimensions with data.
Returns
22
Vs category
94
Consistency
100
Risk-adjusted
45
Drawdown
71
Mean
66
Decision
Quantitative engine reasons behind the buying stance. An explanation can only restate what is already here.
Healthy
Buying stance
Fit for a long SIP
Evidence supports keeping this on a shortlist for a multi-year equity SIP.
Why this status
- No material deterioration, cost shock, or persistent category underperformance in the current evidence set.
Supporting reads
- The fund beat the category median in 100% of rolling 1-year windows.
- Peak-to-trough drawdown has stayed shallower than 15%.
Portfolio
30 Sept 2026 · 70 holdings · top 10 are 29.0%.
- Top 5
- 17.6%
- Top 10
- 29.0%
- Largest holding
- 4.1%
- Effective holdings
- 54.2
Reliance Industries Ltd
Energy & Utilities
4.1%
Axis Bank Ltd
Financial
3.6%
HDFC Bank Ltd
Financial
3.6%
ICICI Bank Ltd
Financial
3.6%
Life Insurance Corporation of India
Financial
2.7%
Worth investigating
Same-category peers with enough history to inspect beside this fund - including tradeoffs.
Axis Value Fund
Axis Mutual Fund
- 1Y
- +1.0%
- 3Y
- +17.9%
- Vol
- 14.5%
- Max DD
- -20.2%
- Sharpe
- 0.67
- 3Y win
- +100%
- Lower volatility
- Lower TER
- Higher trailing returns
Caveat: Deeper drawdown
Canara Robeco Value Fund
Canara Robeco Mutual Fund
- 1Y
- -8.8%
- 3Y
- +10.1%
- Vol
- 13.9%
- Max DD
- -19.0%
- Sharpe
- 0.50
- 3Y win
- +29%
- Lower volatility
- Lower TER
- Higher trailing returns
Caveat: Deeper drawdown
HSBC Value Fund
HSBC Mutual Fund
- 1Y
- -5.1%
- 3Y
- +14.5%
- Vol
- 15.0%
- Max DD
- -19.6%
- Sharpe
- 0.71
- 3Y win
- +100%
- Lower TER
- Higher trailing returns
Caveat: Higher volatility · Deeper drawdown
Groww Value Fund
Groww Mutual Fund
- 1Y
- -6.4%
- 3Y
- +11.7%
- Vol
- 15.3%
- Max DD
- -46.6%
- Sharpe
- 0.38
- 3Y win
- +3%
- Higher trailing returns
Caveat: Higher volatility · Deeper drawdown · Higher TER
JM Value Fund
JM Financial Mutual Fund
- 1Y
- -7.6%
- 3Y
- +10.7%
- Vol
- 18.7%
- Max DD
- -37.9%
- Sharpe
- 0.55
- 3Y win
- +90%
- Higher trailing returns
Caveat: Higher volatility · Deeper drawdown · Higher TER